标题
Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume 110, Issue 1, Pages 14-30
出版商
Oxford University Press (OUP)
发表日期
2017-07-06
DOI
10.1093/jnci/djx160
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oxygen-Enhanced MRI Is a Major Advance in Tumor Hypoxia Imaging
- (2016) M. W. Dewhirst et al. CANCER RESEARCH
- Hypoxia Potentiates the Radiation-Sensitizing Effect of Olaparib in Human Non-Small Cell Lung Cancer Xenografts by Contextual Synthetic Lethality
- (2016) Yanyan Jiang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis
- (2016) Sheng-li Yang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Prognostic significance of hypoxic PET using 18 F-FAZA and 62 Cu-ATSM in non-small-cell lung cancer
- (2016) Tomonari Kinoshita et al. LUNG CANCER
- Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer
- (2016) Anna G. Sorace et al. MOLECULAR IMAGING AND BIOLOGY
- Clinical development of new drug–radiotherapy combinations
- (2016) Ricky A. Sharma et al. Nature Reviews Clinical Oncology
- Imaging biomarker roadmap for cancer studies
- (2016) James P. B. O'Connor et al. Nature Reviews Clinical Oncology
- Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer – A survival model with external validation
- (2016) Sara Carvalho et al. RADIOTHERAPY AND ONCOLOGY
- The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
- (2016) Thomas M. Ashton et al. Nature Communications
- Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study
- (2016) Kate Haslett et al. BMJ Open
- Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
- (2016) Nicole E. Scharping et al. Cancer Immunology Research
- Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer
- (2016) Milan Grkovski et al. EJNMMI Research
- An exploratory study of volumetric analysis for assessing tumor response with 18F-FAZA PET/CT in patients with advanced non-small-cell lung cancer (NSCLC)
- (2016) Gerald S. M. A. Kerner et al. EJNMMI Research
- A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial
- (2015) A. Davidson et al. ANNALS OF ONCOLOGY
- A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)
- (2015) A.-M. C. Dingemans et al. ANNALS OF ONCOLOGY
- AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia
- (2015) D. Moradi Manesh et al. BLOOD
- Validation of functional imaging as a biomarker for radiation treatment response
- (2015) C Jentsch et al. BRITISH JOURNAL OF RADIOLOGY
- Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors
- (2015) David M. Hyman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models
- (2015) J. P. B. O'Connor et al. CANCER RESEARCH
- Prognostic value of18F-fluoroazomycin arabinoside PET/CT in patients with advanced non-small-cell lung cancer
- (2015) Tsuneo Saga et al. CANCER SCIENCE
- Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis
- (2015) R.-H. Tian et al. Clinical & Translational Oncology
- Preclinical Assessment of Efficacy of Radiation Dose Painting Based on Intratumoral FDG-PET Uptake
- (2015) D. Trani et al. CLINICAL CANCER RESEARCH
- TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging
- (2015) S. G. J. A. Peeters et al. CLINICAL CANCER RESEARCH
- Repeatability of hypoxia PET imaging using [18F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial
- (2015) Catharina M. L. Zegers et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion
- (2015) Wouter van Elmpt et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with reversal by Akt inhibition
- (2015) L. MAVROEIDIS et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A Comparative Study of the Hypoxia PET Tracers [18F]HX4, [18F]FAZA, and [18F]FMISO in a Preclinical Tumor Model
- (2015) Sarah G.J.A. Peeters et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
- (2015) Claudia Allemani et al. LANCET
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
- (2015) Jeffrey D Bradley et al. LANCET ONCOLOGY
- IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma
- (2015) Mohamed A. Hassan Metwally et al. RADIOTHERAPY AND ONCOLOGY
- PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes
- (2015) Aniek J.G. Even et al. RADIOTHERAPY AND ONCOLOGY
- Hypoxia as a Cause of Treatment Failure in Non–Small Cell Carcinoma of the Lung
- (2015) Odd Terje Brustugun SEMINARS IN RADIATION ONCOLOGY
- Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer
- (2015) Nils D. Arvold et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays
- (2015) Shigeshi Ono et al. Journal of Clinical Medicine
- Prognostic Impact of Hypoxia-InduciblemiRNA-210in Patients with Lung Adenocarcinoma
- (2015) Jun Osugi et al. Journal of Oncology
- Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
- (2014) S R McKeown BRITISH JOURNAL OF RADIOLOGY
- In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging
- (2014) C. M. L. Zegers et al. CLINICAL CANCER RESEARCH
- Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
- (2014) J. P. B. O'Connor et al. CLINICAL CANCER RESEARCH
- The Meaning, Measurement and Modification of Hypoxia in the Laboratory and the Clinic
- (2014) E.M. Hammond et al. CLINICAL ONCOLOGY
- A prospective clinical study of 18 F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy
- (2014) Stéphanie Servagi-Vernat et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The Tumor Radiobiology of SRS and SBRT: Are More Than the 5 Rs Involved?
- (2014) J. Martin Brown et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
- (2014) Erik O. Pettersen et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Parametric Methods for Quantification of 18F-FAZA Kinetics in Non-Small Cell Lung Cancer Patients
- (2014) E. E. Verwer et al. JOURNAL OF NUCLEAR MEDICINE
- Membrane Carbonic Anhydrase IX Expression and Relapse Risk in Resected Stage I–II Non–Small-Cell Lung Cancer
- (2014) David J. Stewart et al. Journal of Thoracic Oncology
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- (2014) Emilie Lalonde et al. LANCET ONCOLOGY
- Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
- (2014) N. Reinmuth et al. LUNG CANCER
- Hypoxia Increases Gefitinib-Resistant Lung Cancer Stem Cells through the Activation of Insulin-Like Growth Factor 1 Receptor
- (2014) Akiko Murakami et al. PLoS One
- A pilot ‘window of opportunity’ neoadjuvant study of metformin in localised prostate cancer
- (2014) A M Joshua et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: Possible implications for radiotherapy treatment planning strategies
- (2014) Vikram R. Bollineni et al. RADIOTHERAPY AND ONCOLOGY
- Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer
- (2014) Oscar Arrieta et al. RADIOTHERAPY AND ONCOLOGY
- Prognostic Role of Hypoxic Inducible Factor Expression in Non-small Cell Lung Cancer: A Meta-analysis
- (2013) Cong Li et al. Asian Pacific Journal of Cancer Prevention
- A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer
- (2013) A. Eustace et al. CLINICAL CANCER RESEARCH
- Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
- (2013) V. E. Zannella et al. CLINICAL CANCER RESEARCH
- Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients
- (2013) Eline E. Verwer et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer
- (2013) Zhi-Hong Li et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Imaging of hypoxia with18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy
- (2013) Mateya E Trinkaus et al. Journal of Medical Imaging and Radiation Oncology
- Interobserver Agreement of Qualitative Analysis and Tumor Delineation of 18F-Fluoromisonidazole and 3'-Deoxy-3'-18F-Fluorothymidine PET Images in Lung Cancer
- (2013) S. Thureau et al. JOURNAL OF NUCLEAR MEDICINE
- Positive prognostic impact of miR-210 in non-small cell lung cancer
- (2013) Marte Eilertsen et al. LUNG CANCER
- Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastoma
- (2013) Inna V. Linnik et al. MAGNETIC RESONANCE IN MEDICINE
- Computed 88% TCP dose for SBRT of NSCLC from tumour hypoxia modelling
- (2013) Ruggero Ruggieri et al. PHYSICS IN MEDICINE AND BIOLOGY
- Hypoxia imaging with [18F]HX4 PET in NSCLC patients: Defining optimal imaging parameters
- (2013) Catharina M.L. Zegers et al. RADIOTHERAPY AND ONCOLOGY
- Interaction of EGFR with the tumour microenvironment: Implications for radiation treatment
- (2013) Monique M. Nijkamp et al. RADIOTHERAPY AND ONCOLOGY
- MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines
- (2013) S Grosso et al. Cell Death & Disease
- Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia
- (2013) Christopher P. Guise et al. Chinese Journal of Cancer
- PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours
- (2012) Mark J McKeage et al. BMC CANCER
- Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
- (2012) I M Pires et al. BRITISH JOURNAL OF CANCER
- Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors
- (2012) Kunihiko Minakata et al. CANCER SCIENCE
- Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma
- (2012) Guy N.J. Betts et al. EUROPEAN JOURNAL OF CANCER
- Elusive Goal of Targeting Tumor Hypoxia for Therapeutic Gain
- (2012) Lester Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis
- (2012) Sashendra Senthi et al. LANCET ONCOLOGY
- Promise and pitfalls of quantitative imaging in oncology clinical trials
- (2012) Brenda F. Kurland et al. MAGNETIC RESONANCE IMAGING
- A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC)
- (2012) L. Strigari et al. MEDICAL PHYSICS
- Hypoxia-activated prodrugs forge ahead in cancer
- (2012) Jim Kling NATURE BIOTECHNOLOGY
- Imaging hypoxia to improve radiotherapy outcome
- (2012) Michael R. Horsman et al. Nature Reviews Clinical Oncology
- Predicting outcomes in radiation oncology—multifactorial decision support systems
- (2012) Philippe Lambin et al. Nature Reviews Clinical Oncology
- Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer
- (2012) Daniel Zips et al. RADIOTHERAPY AND ONCOLOGY
- FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial
- (2012) Lise Saksø Mortensen et al. RADIOTHERAPY AND ONCOLOGY
- The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer
- (2012) Wouter van Elmpt et al. RADIOTHERAPY AND ONCOLOGY
- Hypoxia Gene Expression Signatures as Prognostic and Predictive Markers in Head and Neck Radiotherapy
- (2012) Kasper Toustrup et al. SEMINARS IN RADIATION ONCOLOGY
- Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells
- (2011) Christoph Wohlkoenig et al. CANCER LETTERS
- Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer
- (2011) K. Toustrup et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial
- (2011) A. M. Lim et al. CLINICAL CANCER RESEARCH
- Selective Tumor Hypoxia Targeting by Hypoxia-Activated Prodrug TH-302 Inhibits Tumor Growth in Preclinical Models of Cancer
- (2011) J. D. Sun et al. CLINICAL CANCER RESEARCH
- Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, a Hypoxia-Activated Prodrug, in Patients with Advanced Solid Malignancies
- (2011) G. J. Weiss et al. CLINICAL CANCER RESEARCH
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- Trends in incidence of small cell lung cancer and all lung cancer
- (2011) Sharma P. Riaz et al. LUNG CANCER
- Dynamic contrast-enhanced-MRI of tumor hypoxia
- (2011) Tormod A.M. Egeland et al. MAGNETIC RESONANCE IN MEDICINE
- Bring on the biomarkers
- (2011) George Poste NATURE
- Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging
- (2011) Kirsti Marie Øvrebø et al. RADIOTHERAPY AND ONCOLOGY
- High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
- (2010) M İlie et al. BRITISH JOURNAL OF CANCER
- Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
- (2010) F M Buffa et al. BRITISH JOURNAL OF CANCER
- Modulating the tumor microenvironment to increase radiation responsiveness
- (2010) Jayashree Karar et al. CANCER BIOLOGY & THERAPY
- Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
- (2010) N. Chan et al. CANCER RESEARCH
- Comparison of 18F-Fluoroerythronitroimidazole and 18F-Fluorodeoxyglucose Positron Emission Tomography and Prognostic Value in Locally Advanced Non–Small-Cell Lung Cancer
- (2010) Ling Li et al. Clinical Lung Cancer
- Ionizing Radiation Activates AMP-Activated Kinase (AMPK): A Target for Radiosensitization of Human Cancer Cells
- (2010) Toran Sanli et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Effect of chronic intermittent hypoxia on biological behavior and hypoxia-associated gene expression in lung cancer cells
- (2010) Yonglei Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
- (2010) Danny Rischin et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
- (2010) Anne Aupérin et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum Osteopontin Levels are Highly Prognostic for Survival in Advanced Non-small Cell Lung Cancer: Results from JMTO LC 0004
- (2010) Shun-Ichi Isa et al. Journal of Thoracic Oncology
- How to improve R&D productivity: the pharmaceutical industry's grand challenge
- (2010) Steven M. Paul et al. NATURE REVIEWS DRUG DISCOVERY
- Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and hypoxia with 18fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study
- (2010) Pierre Vera et al. RADIOTHERAPY AND ONCOLOGY
- Initial results of hypoxia imaging using 1-α-d-(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA)
- (2009) Ernst J. Postema et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Preliminary Study of Oxygen-Enhanced Longitudinal Relaxation in MRI: A Potential Novel Biomarker of Oxygenation Changes in Solid Tumors
- (2009) James P.B. O'Connor et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prospective Trial Incorporating Pre-/Mid-Treatment [18F]-Misonidazole Positron Emission Tomography for Head-and-Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
- (2009) Nancy Lee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Pathophysiologic Correlation Between 62Cu-ATSM and 18F-FDG in Lung Cancer
- (2009) T. G. Lohith et al. JOURNAL OF NUCLEAR MEDICINE
- Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI
- (2009) P. Dirix et al. JOURNAL OF NUCLEAR MEDICINE
- Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan
- (2009) Hugo J.W.L. Aerts et al. RADIOTHERAPY AND ONCOLOGY
- A Phase 1 Open-Label, Accelerated Dose-Escalation Study of the Hypoxia-Activated Prodrug AQ4N in Patients with Advanced Malignancies
- (2008) K. P. Papadopoulos et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003
- (2008) Philip C. Mack et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole
- (2008) Rumi Murata et al. RADIOTHERAPY AND ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started